Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218018 | 0.88 | MAPT (0.78) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| Phosphine SCHEMBL30201038 | 0.86 | MAPT (0.75) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| Ammonia Solution, Strong SCHEMBL29558993 | 0.86 | MAPT (0.75) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| Hydrogen Sulfide SCHEMBL28326954 | 0.86 | MAPT (0.75) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL9156652 | 0.86 | MAPT (0.75) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| Iodide SCHEMBL10484653 | 0.84 | MAPT (0.72) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL1047553 | 0.84 | MAPT (0.70) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL6556688 | 0.84 | MAPT (0.71) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL5528929 | 0.82 | MAPT (0.70) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL9948773 | 0.82 | MAPT (0.70) | MAPTL3MBTL1MAPK1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1100483-B1 | GLUCOCORTICOID-SELECTIVE ANTI-INFLAMMATORY AGENTS | ABBOTT LAB (US) | 2004-09-29 | — | — | EP | claimed |
| US-20230250364-A1 | LAUNDRY CARE COMPOSITIONS, METHODS, AND TEST KITS FOR DETERMINING AUTHENTICITY | PROCTER & GAMBLE (US) | 2023-08-10 | — | — | US | disclosed |
| US-10889717-B2 | Compositions, methods, and test kits for determining authenticity | MILLIKEN & COMPANY (US) | 2021-01-12 | — | — | US | disclosed |
| US-10274490-B2 | Magnetic labeling of bacteria | THE GENERAL HOSPITAL CORPORATION (US) | 2019-04-30 | — | — | US | disclosed |
| US-20190112484-A1 | COMPOSITIONS, METHODS, AND TEST KITS FOR DETERMINING AUTHENTICITY | MILLIKEN & COMPANY | 2019-04-18 | — | — | US | disclosed |
| US-20190112551-A1 | LAUNDRY CARE COMPOSITIONS, METHODS, AND TEST KITS FOR DETERMINING AUTHENTICITY | THE PROCTER & GAMBLE COMPANY | 2019-04-18 | — | — | US | disclosed |
| US-20150125884-A1 | Magnetic Labeling of Bacteria | THE GENERAL HOSPITAL CORPORATION | 2015-05-07 | — | — | US | disclosed |
| US-20150125884-A1 | Magnetic Labeling of Bacteria | THE GENERAL HOSPITAL CORPORATION | 2015-05-07 | — | — | US | disclosed |
| WO-2013187954-A1 | MAGNETIC LABELING OF BACTERIA | THE GENERAL HOSPITAL CORPORATION (US) | 2013-12-19 | — | — | WO | disclosed |
| EP-1767947-B1 | An immunoassay method and kit to leucomalachite green and malachite green | RANDOX LAB LTD (GB) | 2008-10-29 | — | — | EP | disclosed |
| US-20070072242-A1 | Immunoassay method and kit to leucomalachite green and malachite green | RANDOX LABORATORIES LIMITED (GB) | 2007-03-29 | — | — | US | disclosed |
| EP-1767947-A1 | An immunoassay method and kit to leucomalachite green and malachite green | Randox Laboratories Ltd. (GB) | 2007-03-28 | — | — | EP | disclosed |
| US-6166013-A | Glucocortiocoid-selective agents | ABBOTT LABORATORIES (US) | 2000-12-26 | — | — | US | disclosed |
| WO-1997017310-A1 | REVERSIBLE CHARGE-BASED SEQUESTRATION ON SOLID SUPPORT | VERSICOR, INC. (US) | 1997-05-15 | — | — | WO | disclosed |
| US-5605616-A | Reversible charge-based sequestration on solid support | VERSICOR, INC. (US) | 1997-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889717-B2 | Compositions, methods, and test kits for determining authenticity | AHR, AR, ARSA | MAPT 4529/4885L3MBTL1 1116/4885MAPK1 3710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.